Conjunctivitis children
conjunctivitis children management

| Feature | Viral | Bacterial | Allergic |
|---|---|---|---|
| Discharge | Watery | Purulent, crusting | Watery |
| Itching | Mild | Absent | Prominent |
| Laterality | Often bilateral | Uni or bilateral | Bilateral |
| Lymphadenopathy | Yes (preauricular) | No | No |
| Fever | May be present | May be present | Absent |
| Type | Cause | Age of Onset | Key Findings | Treatment |
|---|---|---|---|---|
| Chemical | Erythromycin prophylaxis | First 24 h | Bilateral, watery, negative Gram stain | Watchful waiting; resolves in 48 h |
| Gonococcal | N. gonorrhoeae | 2–7 days | Intense chemosis, copious purulent discharge, gram-negative diplococci | Admit + IV ceftriaxone (50 mg/kg, max 125 mg) single dose; saline eye irrigation; evaluate for disseminated disease |
| Chlamydial | C. trachomatis | 7–14 days | Purulent discharge, intense palpebral erythema | Oral erythromycin 12.5 mg/kg PO q6h × 14 days + erythromycin ophthalmic ointment; may discharge if no pneumonia |
| Other bacterial | S. aureus, H. influenzae, E. coli, Pseudomonas | 7–14 days | Variable; identify by Gram stain | Topical bacitracin-polymyxin; admit for nontypeable H. influenzae |
| Viral (HSV) | HSV-1 or HSV-2 | 14–28 days | Lid edema, dendrites on fluorescein | Admit + IV acyclovir 20 mg/kg q8h × 14–21 days + topical antivirals; avoid steroids |
Gonococcal and herpetic neonatal conjunctivitis can progress to corneal perforation or disseminated disease — both require hospital admission.